Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Low Back Pain and Antibiotic Treatment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00285493
Recruitment Status : Withdrawn (Withdrawn: study halted prematurely, prior to enrollment of first participant)
First Posted : February 2, 2006
Last Update Posted : March 13, 2014
Sponsor:
Collaborator:
Clalit Health Services
Information provided by:
Loewenstein Hospital

Brief Summary:
Clinical trial using antibiotic treatment, namely Rulid, after onset of low back pain.

Condition or disease Intervention/treatment Phase
Low Back Pain Drug: Antibiotics Phase 1

Detailed Description:
Clinical trial using antibiotic treatment, namely Rulid, after onset of low back pain.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 0 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Phase 1 Study of Antibiotic Treatment for Low Back Pain
Study Start Date : January 2006
Actual Primary Completion Date : February 2006
Actual Study Completion Date : February 2006

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. protocol designed to assess or examine persons or groups in a systematic way to identify specific markers for eligibility for further evaluation


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   25 Years to 85 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

- Must be able to swallow tablets

Exclusion Criteria:

- Allergy to antibiotics


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00285493


Sponsors and Collaborators
Loewenstein Hospital
Clalit Health Services
Investigators
Layout table for investigator information
Study Director: Bambi Alyagon, MSc Loewenstein Hospital
Principal Investigator: Shoshana Weiler, MD Loewenstein Hospital
Layout table for additonal information
ClinicalTrials.gov Identifier: NCT00285493    
Other Study ID Numbers: 230859
First Posted: February 2, 2006    Key Record Dates
Last Update Posted: March 13, 2014
Last Verified: June 2011
Keywords provided by Loewenstein Hospital:
low back pain
Additional relevant MeSH terms:
Layout table for MeSH terms
Back Pain
Low Back Pain
Pain
Neurologic Manifestations
Anti-Bacterial Agents
Anti-Infective Agents